Today: 23 April 2026
Glencore share price slips ahead of results — what traders are watching next
17 February 2026
1 min read

Glencore share price slips ahead of results — what traders are watching next

London, Feb 17, 2026, 08:21 GMT — Regular session underway.

Glencore (GLEN.L) slipped 0.4% to 490.9 pence in the early London session on Tuesday, dipping as low as 490.1 pence. The previous close stood at 492.9 pence. So far, the stock’s range has been 490.1 to 495.0 pence.

Glencore plans to release its preliminary full-year 2025 results this Wednesday at 0700 UK time, with a webcast scheduled to kick off at 0830, the company said.

Glencore shares have been on a wild ride lately. Earlier this month, Rio Tinto pulled the plug on takeover discussions, sending Glencore down 7% by the close. Jefferies analyst Christopher LaFemina doesn’t see renewed talks as likely: “not our base case,” he wrote. Reuters

BHP’s half-year numbers landed ahead of expectations, sending its shares up 7% after the release. The miner also bumped up its interim payout. Notably, copper contributed 51% of operating earnings for the first stretch.

BHP unveiled a new long-term silver streaming agreement with Wheaton Precious Metals, locking in a $4.3 billion upfront payment. Wheaton’s cut: 67.5% of the silver output from Peru’s Antamina mine once the transaction wraps up, a sharp jump from the 33.75% share it currently gets through Glencore’s deal. (In a streaming arrangement, buyers pay up front for rights to a portion of future output at a set price.) “Quality silver production is becoming increasingly difficult to source,” Wheaton CEO Randy Smallwood said. Reuters

Glencore’s update will put the spotlight on comments from management regarding its marketing business—the trading unit that tends to move the needle on earnings when the commodity cycle shifts. Traders will dig for hints on cash returns, and watch for any signals on how the company is gauging demand for its core metals and coal.

Commodity prices have been swinging, keeping miners and commodity-tied shares on edge. Gold dropped over 2%, silver followed suit, pressured by a stronger dollar and what Kyle Rodda, senior market analyst at Capital.com, called “lacked a bid” in a thin post-holiday market. Investors are also holding off ahead of the Federal Reserve’s January minutes set for release on Wednesday. Reuters

Stock Market Today

  • Jim Cramer Eyes More Procter & Gamble Shares If Price Dips Below $140
    April 23, 2026, 1:10 PM EDT. On Thursday, Jim Cramer highlighted a market rotation from software to hardware as ServiceNow shares fell 17% post-earnings despite beating forecasts. Chip designer Arm led the hardware rally, surging 6% to record highs, though Cramer expressed concern over its CEO's expanded role at SoftBank. Investor attention turns to Procter & Gamble, which rose over 1% ahead of Friday's earnings. Cramer said he plans to "buy more" shares if the price falls below $140, praising new CEO Shailesh Jejurikar's international expertise. Analysts expect modest earnings per share growth near 1% and organic revenue growth below 2%, with eyes on cost pressures from higher resin prices, a packaging material derived from oil.

Latest article

IREN Stock Jumps as AI Cloud Bet Meets $6 Billion Dilution Test

IREN Stock Jumps as AI Cloud Bet Meets $6 Billion Dilution Test

23 April 2026
IREN shares jumped 7.3% to $51.94 in New York Thursday amid debate over its shift from bitcoin mining to AI cloud services. The company plans to deploy 150,000 Nvidia GPUs by late 2026 and reported $2.8 billion in cash as of January. AI cloud revenue remains small compared to bitcoin mining, with $17.3 million last quarter. IREN can sell up to $6 billion in stock under a new SEC filing.
Hims Adds Lilly’s Zepbound and Foundayo as GLP-1 Price Fight Moves Online

Hims Adds Lilly’s Zepbound and Foundayo as GLP-1 Price Fight Moves Online

23 April 2026
Hims & Hers Health said Thursday its providers can now send prescriptions for Eli Lilly’s Zepbound and Foundayo to LillyDirect, expanding branded obesity drug options on its platform. The move follows a similar deal with Novo Nordisk in March. Hims listed Foundayo from $149 a month and Zepbound from $299. The company previously stopped advertising compounded GLP-1s amid tighter U.S. regulations.
Warren Buffett Successor Greg Abel Tightens Grip on Berkshire Hathaway Portfolio, Pushes New Money Into Japan

Warren Buffett Successor Greg Abel Tightens Grip on Berkshire Hathaway Portfolio, Pushes New Money Into Japan

23 April 2026
Greg Abel now controls about 94% of Berkshire Hathaway’s $300 billion stock portfolio after Todd Combs’ departure, consolidating authority more than Warren Buffett had planned. Abel has kept major U.S. holdings largely intact but increased investments in Japanese firms, including a new $1.8 billion stake in Tokio Marine. Recent portfolio trims, such as Apple and Amazon, reflect Buffett’s last quarter in charge.
Rio Tinto stock in focus before London open as results near after Simandou death
Previous Story

Rio Tinto stock in focus before London open as results near after Simandou death

Northern Star shares tick up with gold stocks as traders eye US inflation data
Next Story

Northern Star shares tick up with gold stocks as traders eye US inflation data

Go toTop